Related Experiment Video

Updated: Jun 23, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Cardiogenic shock: 'going to the mat'--is it needed and does it work?

D R Holmes, E J Topol

    European Heart Journal
    |February 3, 1998
    PubMed

    Insights

    Aggressive treatments, including stenting, can significantly improve survival for high-risk patients experiencing cardiogenic shock. While not a cure, these strategies offer better outcomes for carefully selected individuals.

    Area of Science:

    • Cardiology
    • Critical Care Medicine

    Background:

    • Cardiogenic shock is a life-threatening condition with historically high mortality rates.
    • Emerging data suggest that aggressive treatment strategies can improve survival in select high-risk patients.

    Discussion:

    • Interventions to improve coronary perfusion, restore blood flow to the infarct area (e.g., percutaneous coronary intervention, stenting, bypass surgery), and optimize circulatory support are crucial.
    • Stenting shows promise for improved outcomes compared to conventional percutaneous coronary intervention, particularly regarding TIMI 3 flow, reocclusion rates, and mortality.
    • Selection bias is a factor, as angiography itself has been associated with improved outcomes, regardless of revascularization.

    Key Insights:

    • Aggressive therapies, especially stenting, can significantly reduce the high mortality associated with cardiogenic shock in carefully selected patients.
    • Restoring blood flow to the infarct territory and optimizing circulatory support are key components of effective cardiogenic shock management.
    • Ongoing research and trials are essential to further refine patient selection and treatment protocols.

    Outlook:

    • Further randomized trials are needed to definitively establish the efficacy of various aggressive treatment strategies.
    • Identifying patients at risk for cardiogenic shock and those most likely to benefit from intensive interventions is a critical area of ongoing research.
    • Continued investigation into optimal treatment protocols and resource allocation for cardiogenic shock management is warranted.

    More Related Videos

    The Intra-Aortic Balloon Pump06:13

    The Intra-Aortic Balloon Pump

    Published on: February 5, 2021

    Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

    Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

    Published on: August 16, 2021

    Related Concept Videos

    Blood Pressure Imbalances and Circulatory Shock01:24

    Blood Pressure Imbalances and Circulatory Shock

    Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
    Blood Pressure: Hypertension and Hypotension
    Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
    Cardiopulmonary Resuscitation III: AED Use01:23

    Cardiopulmonary Resuscitation III: AED Use

    Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
    Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

    Cardiopulmonary Resuscitation IV: Pharmacological Management

    Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
    Heart Failure V: Medical Management01:30

    Heart Failure V: Medical Management

    Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...